Medical Properties Trust, Inc.

NYSE:MPW Stock Report

Mkt Cap: US$7.7b

We’ve recently updated our valuation analysis.

Medical Properties Trust Valuation

Is MPW undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MPW?

Other financial metrics that can be useful for relative valuation.

MPW key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue10.5x
Enterprise Value/EBITDA13x
PEG Ratio-0.4x

Price to Earnings Ratio vs Peers

How does MPW's PE Ratio compare to its peers?

The above table shows the PE ratio for MPW vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average40.4x
HR Healthcare Realty Trust
86.3x-15.6%US$8.3b
OHI Omega Healthcare Investors
16.6x-7.9%US$7.1b
PEAK Healthpeak Properties
28.7x-25.3%US$14.9b
DOC Physicians Realty Trust
30x-13.0%US$3.8b
MPW Medical Properties Trust
6.2x-17.3%US$7.7b

Price-To-Earnings vs Peers: MPW is good value based on its Price-To-Earnings Ratio (6.2x) compared to the peer average (40.4x).


Price to Earnings Ratio vs Industry

How does MPW's PE Ratio compare vs other companies in the US REITs Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a5.2%
n/an/an/a

Price-To-Earnings vs Industry: MPW is good value based on its Price-To-Earnings Ratio (6.2x) compared to the US REITs industry average (27.4x)


Price to Earnings Ratio vs Fair Ratio

What is MPW's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MPW PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio6.2x
Fair PE Ratio18.9x

Price-To-Earnings vs Fair Ratio: MPW is good value based on its Price-To-Earnings Ratio (6.2x) compared to the estimated Fair Price-To-Earnings Ratio (18.9x).


Share Price vs Fair Value

What is the Fair Price of MPW when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MPW ($12.93) is trading below our estimate of fair value ($18.04)

Significantly Below Fair Value: MPW is trading below fair value by more than 20%.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst MPW forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$12.93
US$15.38
+19.0%
15.2%US$18.00US$10.00n/a13
Jan ’24US$11.14
US$15.46
+38.8%
18.4%US$19.00US$10.00n/a13
Dec ’23US$12.95
US$16.54
+27.7%
14.0%US$19.00US$10.00n/a13
Nov ’23US$11.55
US$16.69
+44.5%
15.3%US$20.00US$10.00n/a13
Oct ’23US$11.86
US$18.14
+53.0%
11.8%US$23.00US$15.00n/a14
Sep ’23US$14.53
US$18.62
+28.1%
10.9%US$23.00US$15.00n/a13
Aug ’23US$17.20
US$19.79
+15.0%
16.9%US$27.00US$15.00n/a14
Jul ’23US$15.64
US$21.86
+39.8%
15.2%US$27.00US$15.00n/a14
Jun ’23US$18.29
US$22.57
+23.4%
11.7%US$27.00US$18.00n/a14
May ’23US$18.39
US$23.50
+27.8%
10.5%US$27.00US$19.00n/a14
Apr ’23US$21.54
US$24.47
+13.6%
7.9%US$27.00US$19.00n/a15
Mar ’23US$20.27
US$24.93
+23.0%
5.2%US$27.00US$22.00n/a15
Feb ’23US$22.79
US$25.07
+10.0%
5.3%US$27.00US$23.00US$12.9315
Jan ’23US$23.63
US$24.57
+4.0%
5.3%US$27.00US$23.00US$11.1414
Dec ’22US$20.74
US$24.43
+17.8%
5.5%US$27.00US$23.00US$12.9514
Nov ’22US$21.48
US$24.08
+12.1%
5.3%US$27.00US$23.00US$11.5513
Oct ’22US$20.24
US$23.42
+15.7%
5.7%US$27.00US$21.50US$11.8613
Sep ’22US$20.99
US$23.50
+12.0%
5.7%US$27.00US$21.50US$14.5313
Aug ’22US$21.03
US$23.65
+12.5%
5.8%US$27.00US$21.50US$17.2013
Jul ’22US$20.24
US$24.00
+18.6%
5.2%US$27.00US$22.00US$15.6413
Jun ’22US$21.36
US$24.08
+12.7%
3.8%US$25.00US$22.00US$18.2913
May ’22US$22.05
US$24.15
+9.5%
3.6%US$25.00US$22.00US$18.3913
Apr ’22US$21.66
US$23.92
+10.4%
5.3%US$25.00US$20.00US$21.5413
Mar ’22US$21.58
US$23.69
+9.8%
5.6%US$25.00US$20.00US$20.2713
Feb ’22US$21.63
US$22.92
+6.0%
5.0%US$24.00US$20.00US$22.7913

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies